Skip to Content

Month: October 2024

Hungary’s Orbán claims the EU seeks to topple his government as his hostility toward it grows

Associated Press BUDAPEST, Hungary (AP) — Hungarian Prime Minister Viktor Orbán has claimed in a speech that the European Union seeks to topple his government and install a puppet regime. It’s an escalation of open hostility toward the bloc by the member considered Russia’s closest ally. Orbán was marking Hungary’s national holiday commemorating a 1956

Continue Reading

Morena presenta iniciativa para blindar la reforma judicial y otras reformas constitucionales

Ángela Reyes Haczek (CNN Español) — El grupo parlamentario de Morena en el Senado de México propuso este martes reformas para evitar amparos contra adiciones o reformas a la Constitución. La iniciativa plantea modificaciones a los artículos 1, 103, 105 y 107 de la Constitución y detalla que “no procederá el juicio de amparo contra adiciones

Continue Reading

US and Cyprus launch a strategic dialogue to bolster security

NICOSIA, Cyprus (AP) — U.S. and Cypriot officials have launched a strategic dialogue they said would bolster security and stability in a crisis-wracked region through initiatives including counterterrorism training of personnel from Middle Eastern countries. U.S. Assistant Secretary of State for European and Eurasian Affairs James O’Brien said a U.S.-funded center has been training personnel

Continue Reading

La campaña de Trump acusa al partido gobernante británico de injerencia en las elecciones, lo que desata un enfrentamiento con un aliado de EE.UU.

Julia Hernández (CNN) — La campaña de Donald Trump acusó al partido gobernante británico de “flagrante interferencia extranjera” en las elecciones presidenciales de Estados Unidos por un viaje de sus activistas para ayudar a la candidatura de la vicepresidenta Kamala Harris, lo que desató un enfrentamiento con uno de los aliados más estrechos de Washington

Continue Reading

UK regulator approves second Alzheimer’s drug in months but government won’t pay for it

AP Medical Writer LONDON (AP) — Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth the cost to taxpayers. It is the second Alzheimer’s drug to receive such a mixed reception within months. In August, the

Continue Reading
Skip to content